CRBP Appoints Evercore Exec Nishant Saxena CBO, Pre-2026 ASCO Data Shows CRB-701 Durable Responses in HNSCC, Cervical Cancer; CRB-913 Phase 1b Complete
Corbus Pharmaceuticals Holdings, Inc. · PHARMACEUTICAL PREPARATIONS · Now $7.75
-32% in 3d after detection
Post-detection moves
1h
—
1d
-1.4%
3d
-32%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS